Village Farms International Stock Earnings Reports

Village Farms reported a strong start to fiscal 2026 with total net sales up 27% year-over-year to $50.2M and consolidated adjusted EBITDA rising 118% to $9.9M (20% margin). Key drivers were a 171% increase in international medical exports (notably Germany) and continued leadership in Canada (top-5 overall and #1 in dried flower). The company reorganized reporting into a single cannabis segment following its shift to a pure-play cannabis business. Operational highlights include completion of EU GMP capacity upgrades in British Columbia (now claiming the world’s largest EU GMP-certified cannabis facility), Delta 2 expansion planting in Canada with first harvest expected mid-May, and Phase 2 Netherlands facility construction completed (awaiting final certification to begin operations late Q2). Cash at quarter end was ~$56M with net cash of ~$20M; total debt $36M. Q1 cash flow was impacted by a large Canadian corporate tax payment (CAD 16.4M) paid in February; management expects positive consolidated operating cash flow from Q2 onward. The company emphasized discipline on M&A and a patient approach to U.S. opportunities following the federal rescheduling order, while positioning itself as a low-cost, large-scale EU GMP supplier with steady pricing in key international markets.